Aortic Aneurysm Clinical Trial
Official title:
The Pharmacokinetics of Opioids and Sedative/Hypnotics During Selective Cerebral Perfusion
There is a need to understand how long anesthetic drugs last in the brain during surgery on the ascending aorta or aortic arch. Drugs can have a prolonged effect when blood temperature is made cold therefore the influence of temperature needs to be studied. This type of surgery allows us to answer questions about how anesthetic drugs behave when they are given during a routine portion of surgery. Patients will be provided with anesthetic drugs during surgery while on a heart lung machine. After the drug is injected into the heart lung machine it will be delivered to the brain to provide more sleep and pain relief. Immediately after the injection of anesthetic drugs, blood samples will be taken from an existing intravenous line in the neck and plasma drug concentrations measured. This will help us to understand how long drugs last in the brain during this type of surgery.
The purpose of this study is to understand the disposition of sufentanil, midazolam and
morphine when the drugs are introduced into the arterial circulation of the brain. Patients
undergoing surgery on the ascending aorta or aortic arch often require cessation of blood
flow to the organs of the body, while maintaining some degree of blood flow to the brain. In
order to achieve organ protection during the circulatory arrest phase of surgery, the body
is cooled to a core temperature of 28°C. Various techniques including deep hypothermic
circulatory arrest, retrograde cerebral perfusion through the superior vena cava, and
partial or bilateral antegrade selective cerebral perfusion have been proposed as means to
protect the brain from ischemic injury during surgery on the aortic arch. At our institution
selective cerebral perfusion has found success for major aortic surgery. This technique was
devised and first employed by DeBakey and associates, to protect the brain during aortic
arch surgery with bilateral carotid perfusion [1]. Selective cerebral perfusion requires the
surgical construction and placement of a Dacron graft onto the right axillary artery that
when connected to a cardiopulmonary bypass machine it will provide 10 ml/kg/min antegrade
flow for brain perfusion [2]. Cerebral cooling will also decrease the oxygen demand of the
brain. In such a way brain ischemia may be minimized. The nature of major aortic arch
surgery requires independent cerebral circulation or selective cerebral perfusion for a
finite period of time. The cardiopulmonary bypass machine is allowed to perfuse the brain
indirectly by serial flow through the right axillary artery to the innominate artery and
finally to the right carotid artery. Any anesthetic drug that is introduced into the
cardiopulmonary bypass circuit will be delivered the same way. We will take advantage of
this independent circuit to safely deliver anesthetic drugs to the brain via the right
carotid artery during surgery.
A prior study that enrolled 6 patients has shown that the anesthetic administration is safe
and feasible. Patients had no problems related to anesthesia or surgery. All patients left
the hospital in stable condition.
;
Observational Model: Cohort, Time Perspective: Prospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04149600 -
Identification of Genetic Causes of Calcific Aortic Valve Disease
|
||
Enrolling by invitation |
NCT04035356 -
HAART Annuloplasty Device Valve Repair Registry
|
||
Recruiting |
NCT02729064 -
Intraoperative Nasal Insulin Effect on Plasma and CSF Insulin Concentration and Blood Glucose
|
Phase 1 | |
Completed |
NCT02467062 -
Implementation of Non-size Markers Derived From 4D Flow MRI of Patients With Aortic Disease.
|
N/A | |
Completed |
NCT02283307 -
Dual Energy CT Urography With Reduced Iodinated Contrast
|
N/A | |
Completed |
NCT01678261 -
X-chromosome Inactivation, Epigenetics and the Transcriptome
|
N/A | |
Terminated |
NCT01055275 -
Cook Iliac Branch Graft Post-market Registry
|
N/A | |
Completed |
NCT00615888 -
Fast Track Management in Elective Open Infrarenal Aortic Aneurysm Repair
|
N/A | |
Completed |
NCT03510793 -
Microcirculation and Anesthesia in Vascular Surgery
|
||
Completed |
NCT03207568 -
RE-GENERATION: The Safety and Performance of the Relay Pro and Relay NBS Pro Stent-graft Devices in the European Union (EU)
|
N/A | |
Recruiting |
NCT05073991 -
Incidence of Mortality and Complications After Lung Surgery, Open Thoracic Aortic Repair, TEVAR, EVAR.
|
||
Not yet recruiting |
NCT01918969 -
Reference Values of Circulating Endothelial Progenitor Cells
|
N/A | |
Completed |
NCT02000544 -
Clinical Evaluation of a Modular Extracorporeal Circulation Circuit
|
N/A | |
Not yet recruiting |
NCT01918982 -
Circulating Endothelial Progenitor Cells and Aortic Aneurysm
|
N/A | |
Completed |
NCT01256372 -
An Trial of Two Dosing Regimens of AP214 for the Prevention of Kidney Injury in Patients Undergoing Cardiac Surgery
|
Phase 2 | |
Recruiting |
NCT00661518 -
PET/CT Imaging of Aneurysm Wall Inflammation
|
N/A | |
Completed |
NCT00094575 -
Standard Open Surgery Versus Endovascular Repair of Abdominal Aortic Aneurysm (AAA)
|
Phase 4 | |
Recruiting |
NCT04471909 -
NEXUS Aortic Arch Clinical Study to Evaluate Safety and Effectiveness
|
N/A | |
Recruiting |
NCT05603520 -
Phenotyping Heterogeneity and Regionality of the Aorta
|
||
Completed |
NCT03727542 -
Influence of Short AV Delay Permanent Pacing on Matrix Metalloproteinase Levels
|
N/A |